Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Research
Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Articles

Antiproliferative and Antitumor Effects of α-Interferon in Renal Cell Carcinomas: Correlation with the Expression of a Kidney-associated Differentiation Glycoprotein

David M. Nanus, Lawrence M. Pfeffer, Neil H. Bander, Sanjeev Bahri and Anthony P. Albino
David M. Nanus
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lawrence M. Pfeffer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Neil H. Bander
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sanjeev Bahri
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anthony P. Albino
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published July 1990
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Human leukocyte α-interferon (IFN-α) has significant antitumor activity in advanced renal cell carcinoma (RC), with approximately 15% (range, 5 to 29%) of patients subjected to IFN-α therapy exhibiting a major objective response. We assayed 16 RC cell lines for intrinsic sensitivity to the growth-inhibitory effects of recombinant IFN-α. Similar to results observed in patients, cultured RCs could be divided into those that are inhibited by IFN-α and those that are not. In addition, the IFN-α-sensitive or -resistant phenotype of cultured RCs was correlated with surface expression of six unrelated kidney-associated differentiation antigens. The expression of one antigen, a Mr 160,000 glycoprotein (gp160), was found to correlate with resistance to IFN-α. Proliferation of seven RC cell lines expressing gp160 (gp160+) was not significantly inhibited by IFN-α at concentrations as high as 3000 units/ml. In contrast, proliferation of eight of nine RC cell lines lacking expression of gp160 (gp160-) was markedly inhibited by IFN-α. The effect of IFN-α gp160+ and gp160− RC xenografts in nu/nu mice was examined. In separate experiments, two gp160+ RC cell lines and five gp160− RC cell lines were injected s.c. into nu/nu mice; one half of the mice were subsequently treated with 106 units of IFN-α i.p. 3 times a wk, and one half received no IFN-α. Tumors appeared at the sites of inoculation in all mice given injections of gp160+ RC cell lines within 10 to 25 days regardless of INF-α therapy. Mice given injections of gp160− RC cell lines, but not receiving IFN-α, also formed tumors. In contrast, gp160− RC cell lines injected into mice that were treated with IFN-α exhibited a marked sensitivity, as demonstrated by either no tumor formation or delayed tumor formation. We conclude that the absence of gp160 expression by RCs may be predictive of sensitivity to the antitumor effects of IFN-α and, thus, provide a basis for identifying IFN-responsive patients.

Footnotes

  • ↵1 This work was supported in part by the Charles H. Revson Foundation, the American Philosophical Society, a Young Investigator Award from the American Society of Clinical Oncology, The Society of Memorial Sloan-Kettering Cancer Center, and NIH Research Grant GM36716. D. M. N. is a Charles H. Revson Clinical Scholar in Biomedical Research, an American Philosophical Society Daland Fellow, and a 1988 Young Investigator of the American Society of Clinical Oncology. L. M. P. in a Scholar of the Leukemia Society of America. S. B. is a recipient of an American Urological Association Summer Student Fellowship.

  • ↵2 To whom requests for reprints should be addressed, at Memorial Sloan Kettering Cancer Center, Box 167, 1275 York Avenue, New York, NY 10021.

  • Received December 21, 1989.
  • Revision received March 9, 1990.
  • ©1990 American Association for Cancer Research.
PreviousNext
Back to top
July 1990
Volume 50, Issue 14
  • Table of Contents
  • Table of Contents (PDF)
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)

Sign up for alerts

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Antiproliferative and Antitumor Effects of α-Interferon in Renal Cell Carcinomas: Correlation with the Expression of a Kidney-associated Differentiation Glycoprotein
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Antiproliferative and Antitumor Effects of α-Interferon in Renal Cell Carcinomas: Correlation with the Expression of a Kidney-associated Differentiation Glycoprotein
David M. Nanus, Lawrence M. Pfeffer, Neil H. Bander, Sanjeev Bahri and Anthony P. Albino
Cancer Res July 15 1990 (50) (14) 4190-4194;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Antiproliferative and Antitumor Effects of α-Interferon in Renal Cell Carcinomas: Correlation with the Expression of a Kidney-associated Differentiation Glycoprotein
David M. Nanus, Lawrence M. Pfeffer, Neil H. Bander, Sanjeev Bahri and Anthony P. Albino
Cancer Res July 15 1990 (50) (14) 4190-4194;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Tissue Structure, Nuclear Organization, and Gene Expression in Normal and Malignant Breast
  • Introduction of Suzanne Cory
  • The Phenotypes Associated with ret Mutations in the Multiple Endocrine Neoplasia Type 2 Syndrome
Show more Articles
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement